PAMELA CALVERT: Open Payments
NPI 1013689611 · BATESVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$602 in 26 payments from 10 companies in 2025. Trend: 2023 $17 · 2024 $0 · 2025 $602
Food & beverage: $602
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $149 |
| ABBVIE INC. | 10 | $136 |
| Amgen Inc. | 2 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $52 |
| Novo Nordisk Inc | 2 | $34 |
| Boston Scientific Corporation | 1 | $34 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Ardelyx, Inc. | 1 | $17 |
Products named: AIRSUPRA, REPATHA, QULIPTA, Kerendia, UBRELVY, WATCHMAN FLX, INSPIRE, REXULTI.
Industry payments across MS — which companies pay providers there.
